RNRaphael Ndahimana

Raphael Ndahimana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Raphael Ndahimana has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Undiagnosed hypertension and its determinants among adults in Rwanda in the 2021–2022 WHO STEPS survey

    by Pasteur Dushimimana, Raphael Ndahimana, Jean Marie Vianney Sindambiwe, Uwayo Akizanye Sylvie, Emmanuel Kalisa, Jean Pierre Nizeyimana, Philemon Manishimwe, Shema Marie Antoinette, Israel Cyubahiro Munyambaraga

    Hypertension remains a major public health concern in Rwanda, yet many affected adults remain undiagnosed. This study examined the extent and determinants of undiagnosed hypertension using data from the nationally representative 2021–2022 Rwanda STEPS Survey. A total of 1,223 adults aged 18–69 years who met clinical criteria for hypertension were included in this cross-sectional analysis. Survey-adjusted multivariable binary logistic regression was used to identify factors associated with being undiagnosed. Overall, 42.9% (95% CI: 39.1–46.9; n = 524 ) of hypertensive adults were unaware of their condition. Younger adults were significantly more likely to be undiagnosed, particularly those aged 18–24 years (AOR = 2.9, 95% CI: 1.30–6.30, p = 0.009) and 25–34 years (AOR = 1.9, 95% CI: 1.11–3.20, p = 0.020). Men had more than double the odds of being undiagnosed compared with women (AOR = 2.7, 95% CI: 1.82–3.96, p < 0.001). Higher education was protective, while residents of the Western Province showed elevated odds (AOR = 1.8, 95% CI: 1.07–3.05, p = 0.026). Not visiting a health worker in the past year was the strongest predictor of remaining undiagnosed (AOR = 3.2, 95% CI: 2.33–4.51, p < 0.001). These findings highlight the need to expand routine blood pressure screening to younger adults and men, and to strengthen community-based detection efforts across Rwanda.

  • Open Access

    Prevalence and determinants of meeting minimum meal frequency among children aged 6–23 months in Rwanda: a cross-sectional study

    by Absolomon Gashaija, Marie Josée Mwiseneza, Candide Girimpundu Mugeni, Raphael Ndahimana, Mediatrice Niyonsaba, Félicien Irafasha, Charles Ndayisaba, Adalbert Ndayisenga, Roger Muragire, Binayisa Gad, et al.

    Introduction: Inadequate minimum meal frequency (MMF) contributes to malnutrition among infants and young children, increasing the risk of stunting, micronutrient deficiencies, impaired cognitive development and higher morbidity and mortality. In Rwanda, limited data exist on the prevalence and determinants of meeting MMF among children aged 6–23 months. This study aimed to determine the prevalence and determinants of meeting MMF in this population. Methods: A cross-sectional study was conducted using secondary data from the 2019–2020 Rwanda Demographic and Health Survey, comprising 1203 children aged 6–23 months. The main outcome was meeting MMF, defined according to WHO guidelines as receiving the minimum recommended number of meals per day, based on age and breastfeeding status. Bivariate analysis using χ² tests and binary logistic regression was conducted to determine the determinants of meeting MMF. Variables with a p<0.05 were included in a multivariable logistic regression model. Results: The prevalence of meeting MMF was 46.1%. Four factors were independently associated with meeting MMF. Children from the poorest households had 70% lower odds of meeting MMF (adjusted OR (AOR)=0.298, 95% CI 0.124 to 0.717). Children whose mothers earned less than their husbands had 53% lower odds of meeting MMF (AOR=0.466, 95% CI 0.235 to 0.924). Children who experienced recent diarrhoeal illness had 57% lower odds of meeting MMF (AOR=0.434, 95% CI 0.267 to 0.706). Additionally, lack of postnatal care visits was associated with 45% lower odds of meeting MMF (AOR=0.551, 95% CI 0.328 to 0.926, p=0.024). Conclusions: The study revealed that less than half (46.1%) of the Rwandan children aged 6–23 months met the MMF requirement. Key factors negatively associated included household poverty, maternal income inequality, recent diarrhoeal diseases and lack of postnatal care visits. These findings underscore the need for integrated socioeconomic and healthcare interventions.

  • Top Cited Papers
    Open Access

    The Global Landscape of Plasmodium falciparum Drug Resistance Markers, 2005–2025: A Systematic Review and Meta-Analysis

    by Felix Habarugira, Jeanne Batamuriza, Raphael Ndahimana, Jules Ndoli Minega, Mame Massar Dieng, Masceline Jenipher Mutsaka-Makuvaza, Tolessa Muleta Daba, Youssef Idaghdour, Leon Mutesa

    Malaria remains a global health threat, with Plasmodium falciparum causing most deaths, especially in sub-Saharan Africa. Although artemisinin-based therapies reduce the burden, drug-resistant parasites threaten control efforts. Mapping the distribution and evolution of molecular resistance markers is vital for evidence-based strategies. This systematic review mapped the global distribution, pooled prevalence, and temporal trends of key P. falciparum antimalarial resistance markers. Following the PRISMA methodology (PROSPERO: CRD4202511098991), databases (PubMed, Web of Science, Scopus, and Google Scholar) and gray sources were searched (July 2005–July 2025). Data were extracted in Rayyan, assessed via the JBI prevalence tool, and analyzed using Python v3.13 for WHO regional distribution, temporal trends, and treatment outcome trends. Of the 1972 records, 261 studies from 64 countries qualified for inclusion in this review. The pooled prevalence was highest for pfdhfr (85.7%), followed by pfcrt (78.0%), pfdhps (73.7%), pfmdr1 (60.5%), and pfk13 (45.0%). High heterogeneity (I2 > 95%) and rising pfk13 since 2012 highlight emerging artemisinin resistance, while persistent pfdhfr/pfdhps mutations show that ongoing sulfadoxine–pyrimethamine (SP) pressure on P. falciparum drug resistance, decreased parasite clearance, and treatment failure remain widespread and evolving in Africa. Integrating molecular surveillance into national malaria programs is essential to guide treatment modalities and support progress toward malaria elimination.


  • Predictors for Delayed First Antenatal Care Visit in Rural Area of Rwanda: Evidence from Rwanda Demographic Health Survey 2019-2020

    by Japhet Ishimwe, Odille Niyibizi, Aphrodis Tuyishime, Joseph Imanishimwe, John Mugisha, Absolomon Gashaija, Raphael Ndahimana, Roger Muragire, Marie Munezero, Gad Binayisa, et al.

    Background: Timely commencement of antenatal care (ANC) improves maternal outcomes by reducing complications that often result in death. According to the World Health Organization, 800 women died daily in 2020 from preventable complications related to pregnancy and childbirth, with almost 95% occurring in low and middle-income countries where Rwanda is located. Therefore, this study aimed to determine predictors of delayed first ANC visits in rural areas of Rwanda. Methods: This cross-sectional study utilized the Rwanda Demographic and Health Survey (RDHS) data, enrolling a weighted sample of 5,060 women who had been pregnant within the five years preceding the survey. Logistic regression modeling identified socio-demographic and maternal characteristics associated with delayed first ANC visits. Results: The prevalence of delayed first ANC visits was 40.2%. After adjustment of variables in a multivariate regression model, factors associated with the delays included low wealth index, marital status, maternal age (25-34 and 35-49), having 2-4 or more than 4 children, and occupation. Health insurance coverage was a protective factor against the delays of ANC. Conclusion: The findings highlight the need for interventions at multiple levels to increase timely uptake of the first antenatal care visit, as the study revealed socio-demographic and maternal factors that significantly influence delays in initiating antenatal care.

  • Open Access

    Prevalence and predictors of critical COVID-19 pneumonia among patients with COVID-19 admitted at Nyarugenge major COVID-19 Referral Center in Rwanda

    by Mukantagengwa Marie Paul, Ndahimana Raphael, Nkeshimana Menelas, Abimana Deborah, Uwineza Jean Bonaventure, Dushimimana Pasteur, Murekatete Marie Beata, Muhizi Epaphrodite, Hafashimana Valens, Ndayisaba Prosper, et al.

    Coronavirus Disease 2019(COVID-19) pneumonia, caused by the Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2 virus), remains a significant global health challenge, contributing to millions of cases and deaths worldwide, including a substantial burden in Rwanda. Severe and critical cases often lead to respiratory failure, multi-organ dysfunction, and increased mortality. Despite global research, data on predictors of critical illness among hospitalized COVID-19 patients in Rwanda remain limited, highlighting the need for context-specific studies. This study aimed to assess the prevalence and identify risk factors for critical COVID-19 pneumonia among patients admitted to the Nyarugenge Major COVID-19 Referral Center in Rwanda. A mixed-study design combining retrospective and prospective designs was conducted from February to October 2021, and we included 320 patients aged 15 to 65 years admitted with severe or critical COVID-19 pneumonia. Data were collected on socio-demographic factors, vital signs, and clinical symptoms. Multivariate logistic regression was performed using Stata 17 to identify independent predictors of critical illness. Of the 320 patients, 30% presented with critical illness, while 70% had severe illness. Independent predictors of critical illness included oxygen saturation ≤ 90% {Adjusted Odds Ratio (AOR) = 5.83, 95% Confidence Interval(CI): 2.95–11.52, p < 0.001), respiratory rate > 20 beat per minute(bpm), (AOR = 2.34, 95% CI: 1.11–4.93, p < 0.05), and heart rate > 100 bpm (AOR = 2.49, 95% CI: 1.32–4.67, p < 0.01). Critical illness was prevalent in 30% of patients, with hypoxia, tachypnea, and tachycardia as significant predictors. These findings identify key clinical predictors of critical COVID-19 pneumonia and suggest that monitoring these indicators may help guide early intervention and optimize resource allocation in Rwanda and similar low- and middle-income settings. Not applicable.


  • Open Access

    Occurrence of Intestinal Parasites among Suspected Patients Attending Rubungo Health Center in Rwanda: Trend Analysis of Registry Records

    by Raphael Ndahimana, Melissa Uwase, Josepha Nathy Umutoni, Eddy Irakoze, Shemsa Uwimana, Clement Bigenimana, Daniel Uwitonze, Parfait Ndizeye, Charite Byiringiro, Roger Muragire, et al.

    BackgroundIntestinal parasitic infections are still a public health problem globally, affecting 3.5 billion people each year. This study aimed to assess the occurrence of intestinal parasites among suspected patients attending Rubungo Health Center in Rwanda.MethodsThis study used a quantitative retrospective cross-sectional design. A review of records on intestinal parasitic infections among both inpatients and outpatients who visited Rubungo Health Center between 2015 and 2019 was conducted. We used descriptive analysis and a chi-square test and logistic regression analysis to determine the significant factors associated with intestinal parasites.ResultsOut of 389 patients tested for intestinal parasites, 62.7% were positive. From 2015 to 2018, cases showed a declining trend, but there was a sharp increase in 2019 to 22.1% from 14.3% in 2018, a change that showed marginal statistical significance (p = 0.054). Males were 2.16 times more likely to have Entamoeba histolytica than females (AoR: 2.16, 95%:1.10-4.16). E. histolytica was the most common parasite, with fluctuating prevalence, peaking in 2016-2018 and reaching 14.8% in 2015 and 2019. Age categories showed a significant positive association with E. histolytica parasite.ConclusionThis study highlights a high prevalence of intestinal parasites in the Rubungo Health Center catchment area. The persistence of these infections despite WASH interventions suggests inadequate implementation and a need to strengthen the continued health education in the community to all age groups.Rwanda J Med Health Sci 2025;8(2): 285-294


  • Open Access

    Prevalence and associated risk factors of stunting too early: analysis of the 2020 Rwanda demographic and health survey

    by Raphael Ndahimana, Melissa Uwase, Roger Muragire, Alliance Uwase, Edith Uwamahoro, Bwiza Flavia, Elysee Niyonganyira, Ayinkamiye Esperance, Divine Umutesi Rusa, Marie Josée Mwiseneza, et al.

    Background: Stunting in young children continues to be a public health concern in Rwanda. The effect of stunting in the first 1000 days of life has long-term consequences, including decreased brain development and a higher risk of developing diseases later in life. To design proper interventions, identifying the risk factors of stunting too early is paramount. The study thus aimed to identify the prevalence of stunting too early (6–23 months) and its associated risk factors. Methods: The research study analysed secondary data from the nationally conducted demographic health survey of 2019–2020, which was analysed by using bivariate analysis and multivariable logistic regression models to determine the factors associated with stunting that occurred too early. P value of <0.05, regression coefficients and their 95% CI were used to assess the level of significance as well as insights related to the strength and direction of the relationship between being stunted too early and other covariates. Results: A total of 1180 children aged 6–23 months were included in the analysis. The overall prevalence of stunting too early was 30% with a 95% CI of 27.4%–32.6%. Moreover, the prevalence of stunting was 29.0%, 20.0%, 23.0% and 35% among the 6 months, 7–8 months, 9–12 months and 13–23 months age groups, respectively. After adjusting for potential confounding variables, the following factors were independently associated with stunting too early: being male (aOR:2.3; 95% CI:1.68 to 3.00), not currently being breastfed (aOR:1.97, 95% CI:1.21 to 3.19), mothers aged 25–34 and more than 34 years (aOR:1.64; 95% CI:1.11 to 2.43) and (aOR:1.63; 95% CI:1.07 to 2.47), respectively, households with poor wealth index (aOR:2.61; 95%CI: 1.72 to 3.09), child age group of 13–23 months (aOR:2.00; 95% CI:1.14 to 5.51) and small child size at birth (aOR:2.36; 95% CI:1.42 to 3.92). Conclusions: The prevalence of stunting too early was high, and the factors significantly associated with it were the sex and age of the child, the mother’s age, low socio-economic status and small child size at birth. There is a need to address those factors through campaigns of health education, emphasis on girls’ education for their empowerment and strengthening of nutritional programme implementation.